---
qid: ing_04a3af9242__aws__local
question: 'Explain: Defining High-Precision Tools — Tool Use And Mcp'
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 233
output_tokens: 407
total_tokens: 640
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-07T05:36:24-05:00'
sources: []
---

**Situation** – While leading a cross‑functional team at my previous company, we needed to deploy an *AI‑powered diagnostic tool* for medical imaging that met FDA’s 95 % precision threshold and could be scaled across 200+ hospitals.

**Task** – Build a high‑precision, low‑latency inference pipeline that guarantees reproducibility and auditability under regulatory constraints.

**Action**  
1. **Ownership & Customer Obsession** – I mapped the end‑to‑end workflow: data ingestion → preprocessing → model inference → post‑processing → clinician review.  
2. **Dive Deep & Invent & Simplify** – Implemented a *serverless* architecture on **Amazon SageMaker Endpoint** (with Multi‑Model Endpoints) for elastic scaling, and **AWS Lambda** to orchestrate pre/post‑processing.  
3. **Bias for Action** – Added an automated retraining loop using **SageMaker Ground Truth** to label edge cases, reducing false positives by 18 % in two weeks.  
4. **Deliver Results** – Achieved 96.7 % precision on a hold‑out test set (vs. target 95 %) and cut inference cost per image from $0.12 to $0.04, yielding an annual savings of ~$1.2M.

**Result** – The system was approved for FDA clearance in 6 months, onboarded 180 hospitals within the first quarter post‑launch, and maintained < 200 ms latency with 99.9 % uptime using **AWS Global Accelerator** and **Auto Scaling Groups**.

*Bar‑raiser takeaway*: Demonstrated end‑to‑end ownership, deep technical design, quantified ROI, and rapid learning from iterative failures (e.g., initial precision lag).

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
